Received Jul 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 5XA2J | — |
received the previous dosing schedule of 0 and more than 1 month instead of the current dosing schedule; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in an unspecified number of patients who received Men B NVS (Bexsero) (batch number 5XA2J) for prophylaxis. On an unknown date, the patients received Bexsero .5 ml. On an unknown date, an unknown time after receiving Bexsero, the patients experienced inappropriate schedule of vaccine administered (Verbatim: received the previous dosing schedule of 0 and more than 1 month instead of the current dosing schedule). The outcome of the inappropriate schedule of vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 09-JUL-2025 The reporter was a Health Care Professional. The reporter stated that patients (unspecified amount) received Bexsero outside of the current dosing recommendations The patients received the previous dosing schedule of 0 and more than or equal to 1 month instead of the current dosing schedule which led to inappropriate schedule of vaccine administered. The HCP did not have specific patient identifiers